Somatic PIK3R1 mutations in the iSH2 domain are accessible to PI3Kα inhibition.

Morin G, Garneau AP, Bouzakher N, Ségot L, Fraissenon A, Blondel A, Petit F, Chopinet C, Mayeux F, Fayoux P, Dompmartin A, Bodemer C, Balducci E, Kaltenbach S, Villarese P, Asnafi V, Legendre C, Broissand C, Fraitag S, Quelin C, Goudin N, Guibaud L, Canaud G

Open source

DOI
10.1038/s44321-025-00249-9
Published
2025 Jul
Container
EMBO molecular medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s44321-025-00249-9,
  title = {Somatic PIK3R1 mutations in the iSH2 domain are accessible to PI3Kα inhibition.},
  author = {Morin G and Garneau AP and Bouzakher N and Ségot L and Fraissenon A and Blondel A and Petit F and Chopinet C and Mayeux F and Fayoux P and Dompmartin A and Bodemer C and Balducci E and Kaltenbach S and Villarese P and Asnafi V and Legendre C and Broissand C and Fraitag S and Quelin C and Goudin N and Guibaud L and Canaud G},
  year = {2025},
  journal = {EMBO molecular medicine},
  doi = {10.1038/s44321-025-00249-9},
  url = {https://doi.org/10.1038/s44321-025-00249-9}
}

RIS

TY  - JOUR
TI  - Somatic PIK3R1 mutations in the iSH2 domain are accessible to PI3Kα inhibition.
AU  - Morin G
AU  - Garneau AP
AU  - Bouzakher N
AU  - Ségot L
AU  - Fraissenon A
AU  - Blondel A
AU  - Petit F
AU  - Chopinet C
AU  - Mayeux F
AU  - Fayoux P
AU  - Dompmartin A
AU  - Bodemer C
AU  - Balducci E
AU  - Kaltenbach S
AU  - Villarese P
AU  - Asnafi V
AU  - Legendre C
AU  - Broissand C
AU  - Fraitag S
AU  - Quelin C
AU  - Goudin N
AU  - Guibaud L
AU  - Canaud G
PY  - 2025
JO  - EMBO molecular medicine
DO  - 10.1038/s44321-025-00249-9
UR  - https://doi.org/10.1038/s44321-025-00249-9
ER  - 

APA

G, M., AP, G., N, B., L, S., A, F., A, B., F, P., C, C., F, M., P, F., A, D., C, B., E, B., S, K., P, V., V, A., C, L., C, B., S, F., C, Q., N, G., L, G., & G, C. (2025). Somatic PIK3R1 mutations in the iSH2 domain are accessible to PI3Kα inhibition.. EMBO molecular medicine. https://doi.org/10.1038/s44321-025-00249-9

Source records